September 27, 1999
New Drug May Halt Vision Loss
by Dan Roberts September 27, 1999 A new anti-angiogenesis agent called PKC 412 has halted abnormal growth of retinal blood vessels which cause vision loss in macular degeneration and diabetic retinopathy. It is made by Novartis Ltd. Pharmaceuticals, and much of the lab work is being done by Dr. Peter Campochiaro, professor of ophthalmology and […]